IPO Timeline
Broker Results (T-2)
2021-12-09
Some brokers release in afternoon
Grey Market (T-1)
2021-12-10
Afternoon
HKEX Allotment (T-1)
2021-12-10
Evening
Registrar Allotment (T-1)
2021-12-10
Evening
Listing Day (T)
2021-12-13
First day of trading
Company Overview
| Stock Name | 雍禾醫療集團有限公司 |
|---|---|
| Stock Code | 02279 |
| Company Full Name | 雍禾醫療集團有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 主要於中國提供毛發醫療服務。 |
| Listing Date | 2021-12-13 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國北京市朝陽區甘露園南里20號中國核建大廈11層 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | http://www.yonghegroup.cn |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 15.80 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 50.0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 745,949,600 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 16.6 |
|---|---|
| First Day Open | HK$ 15.76 |
| First Day Change | -85.44% |
| First Day Volume | 61374600.0 |
| First Day Turnover | 1026880000.0 |
Use of Proceeds
| Use of Proceeds | 1、約42.1%或571.2百萬港元將用于為我們在中國境內網絡的現有植發醫療機構進行擴充和升級； 2、約17.5%或237.4百萬港元將用于為我們的產品及服務項目創新撥資； 3、約9.7%或131.6百萬港元將用作投資于研發，及以前沿技術提升我們的服務體系； 4、約23.4%或317.5百萬港元將用作在中國整合行業資源以提升我們的品牌知名度； 5、約1.6%或21.7百萬港元將用作結清我們就于2021年5月收購顯赫植發應付關聯方新絲域的并購代價之未償還結余； 6、約5.7%或77.3百萬港元將用作我們的營運資金及一般企業用途。 |
|---|
Underwriting Syndicate
Joint Sponsors (2)
摩根士丹利亚洲有限公司 CE AAD291
中国国际金融香港证券有限公司 CE AEN894
Overall Coordinators (2)
摩根士丹利亚洲有限公司 CE AAD291
中国国际金融香港证券有限公司 CE AEN894
Joint Bookrunners (2)
摩根士丹利亚洲有限公司 CE AAD291
中国国际金融香港证券有限公司 CE AEN894
Joint Lead Managers (2)
摩根士丹利亚洲有限公司 CE AAD291
中国国际金融香港证券有限公司 CE AEN894
Cornerstone Investors
| # | Investor Name | Investment Amount | Shares Subscribed | % of Offer Shares | % of Total Shares | Lock-up Period | Est. Unlock Date |
|---|---|---|---|---|---|---|---|
| 1 | Athos Asia Event Driven Master Fund | 38,457,200 HKD | — | 2.58% | — | 6 months | 2022-06-13 |
| 2 | Enreal China Master Fund | 76,898,600 HKD | — | 5.15% | — | 6 months | 2022-06-13 |
| 3 | Hudson Bay Master Fund LTD | 76,898,600 HKD | — | 5.15% | — | 6 months | 2022-06-13 |
| 4 | Lake Bleu Prime Healthcare Master Fund Limited | 76,898,600 HKD | — | 5.15% | — | 6 months | 2022-06-13 |
| 5 | LAV Star Limited | 76,898,600 HKD | — | 5.15% | — | 6 months | 2022-06-13 |
| 6 | NCC China A-Share Master Fund | 153,805,100 HKD | — | 10.31% | — | 6 months | 2022-06-13 |
| 7 | WT Asset Management Limited | 76,898,600 HKD | — | 5.15% | — | 6 months | 2022-06-13 |
| 8 | Yi Fang Da Hadar Investment Limited | 76,898,600 HKD | — | 5.15% | — | 6 months | 2022-06-13 |
| 9 | York Asian Opportunities Investments Master Fund, LP | 38,457,200 HKD | — | 2.58% | — | 6 months | 2022-06-13 |
| 10 | 常春藤资产管理(香港)有限公司 | 53,838,500 HKD | — | 3.61% | — | 6 months | 2022-06-13 |
Directors & Management
| Chairman | 張玉 |
|---|---|
| Company Secretary | 伍偉琴 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 張玉(34.44%);磐茂(上海)投資中心(有限合夥)(17.43%);CYH Cosmetic Medical Investment Limited(17.43%) |
|---|
IPO Timeline
